DPP-4-话题@MedSci

#DPP-4#

57篇内容 | 2190人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1401955, encodeId=5218140195516, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？, objectType=article, longId=156533, objectId=8846156533e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8846156533e5, replyNumber=0, likeNumber=0, createdTime=2018-12-25, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8846156533e5, moduleTitle=DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8846156533e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401954, encodeId=d3591401954a3, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=BMJ：DPP-4抑制剂以及GLP-1激动剂或导致糖尿病患者胆管癌风险增加, objectType=article, longId=155614, objectId=db9d15561414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db9d15561414, replyNumber=0, likeNumber=65, createdTime=2018-12-13, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db9d15561414, moduleTitle=BMJ：DPP-4抑制剂以及GLP-1激动剂或导致糖尿病患者胆管癌风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db9d15561414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401953, encodeId=903f1401953ba, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用, objectType=article, longId=155570, objectId=3d4d1555e01e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4d1555e01e, replyNumber=0, likeNumber=40, createdTime=2018-12-12, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4d1555e01e, moduleTitle=Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4d1555e01e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401952, encodeId=f7181401952fb, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类, objectType=article, longId=139721, objectId=9b09139e213c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b09139e213c, replyNumber=0, likeNumber=35, createdTime=2018-06-03, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b09139e213c, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b09139e213c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401951, encodeId=f11e140195174, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！, objectType=article, longId=131332, objectId=476e131332d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=476e131332d6, replyNumber=0, likeNumber=32, createdTime=2018-03-05, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=476e131332d6, moduleTitle=Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=476e131332d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401950, encodeId=571c140195077, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：治疗2型糖尿病 SGLT-2is或比DPP-4is更胜一筹, objectType=article, longId=128540, objectId=2fed12854081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fed12854081, replyNumber=0, likeNumber=60, createdTime=2018-02-03, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fed12854081, moduleTitle=Diabetes Obes Metab：治疗2型糖尿病 SGLT-2is或比DPP-4is更胜一筹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fed12854081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401949, encodeId=9786140194997, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星, objectType=article, longId=125868, objectId=eb8e12586871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb8e12586871, replyNumber=0, likeNumber=0, createdTime=2018-01-09, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb8e12586871, moduleTitle=Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb8e12586871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401948, encodeId=22a71401948c3, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Care：2型糖尿病GLP-1 RA和DPP-4治疗：真实世界有效性数据为何比RCT差？, objectType=article, longId=124969, objectId=962b12496943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=962b12496943, replyNumber=0, likeNumber=59, createdTime=2017-12-30, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=962b12496943, moduleTitle=Diabetes Care：2型糖尿病GLP-1 RA和DPP-4治疗：真实世界有效性数据为何比RCT差？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=962b12496943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401947, encodeId=5d3d140194e01, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Care：“调解官”二甲双胍能改善DPP-4抑制剂对心血管的影响？, objectType=article, longId=124730, objectId=d2be124e3032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2be124e3032, replyNumber=0, likeNumber=64, createdTime=2017-12-28, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2be124e3032, moduleTitle=Diabetes Care：“调解官”二甲双胍能改善DPP-4抑制剂对心血管的影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2be124e3032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401946, encodeId=7ec61401946cf, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：DPP-4抑制剂不对β细胞功能造成影响, objectType=article, longId=124210, objectId=44971242109d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44971242109d, replyNumber=0, likeNumber=70, createdTime=2017-12-23, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44971242109d, moduleTitle=Diabetes Obes Metab：DPP-4抑制剂不对β细胞功能造成影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44971242109d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401945, encodeId=cabc14019458e, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Care：二甲双胍或可调节DPP-4抑制剂对心血管结局的影响。, objectType=article, longId=117983, objectId=dbcf11e98358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbcf11e98358, replyNumber=0, likeNumber=75, createdTime=2017-10-30, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbcf11e98358, moduleTitle=Diabetes Care：二甲双胍或可调节DPP-4抑制剂对心血管结局的影响。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbcf11e98358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401944, encodeId=de17140194402, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：DPP-4抑制剂和SU治疗的HHF风险无组内差异, objectType=article, longId=117597, objectId=6cd411e59781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cd411e59781, replyNumber=0, likeNumber=83, createdTime=2017-10-27, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cd411e59781, moduleTitle=Diabetes Obes Metab：DPP-4抑制剂和SU治疗的HHF风险无组内差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cd411e59781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401943, encodeId=1fe814019439f, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局, objectType=article, longId=115971, objectId=da471159e1cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da471159e1cb, replyNumber=0, likeNumber=73, createdTime=2017-10-14, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da471159e1cb, moduleTitle=Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da471159e1cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401942, encodeId=189d140194242, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者采用DPP-4i和达格列净治疗的效果比较！, objectType=article, longId=110312, objectId=a4b011031233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4b011031233, replyNumber=0, likeNumber=90, createdTime=2017-08-22, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4b011031233, moduleTitle=Diabetes Obes Metab：2型糖尿病患者采用DPP-4i和达格列净治疗的效果比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4b011031233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401941, encodeId=2caa14019418c, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：初始DPP-4是否增加老年糖尿病患者心血管事件风险？, objectType=article, longId=106690, objectId=b03410669017, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b03410669017, replyNumber=0, likeNumber=49, createdTime=2017-07-27, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b03410669017, moduleTitle=Diabetes Obes Metab：初始DPP-4是否增加老年糖尿病患者心血管事件风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b03410669017)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401940, encodeId=65361401940cd, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者采用DPP-4is和SGLT-2is治疗疗效和安全性比较！, objectType=article, longId=103968, objectId=8f33103968a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f33103968a3, replyNumber=0, likeNumber=35, createdTime=2017-07-01, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f33103968a3, moduleTitle=Diabetes Obes Metab：2型糖尿病患者采用DPP-4is和SGLT-2is治疗疗效和安全性比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f33103968a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401939, encodeId=c0e9140193982, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=JAHA:DPP-4抑制剂阿拉格列丁能够抑制颅内动脉瘤的形成, objectType=article, longId=102909, objectId=ac111029097a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac111029097a, replyNumber=0, likeNumber=55, createdTime=2017-06-23, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac111029097a, moduleTitle=JAHA:DPP-4抑制剂阿拉格列丁能够抑制颅内动脉瘤的形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac111029097a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401938, encodeId=ef8e1401938ca, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Care：DPP-4抑制刺激2型糖尿病患者远端肾小管尿钠排泄以及增加循环SDF-1α1-67！, objectType=article, longId=99888, objectId=e92d9988838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92d9988838, replyNumber=0, likeNumber=36, createdTime=2017-05-28, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92d9988838, moduleTitle=Diabetes Care：DPP-4抑制刺激2型糖尿病患者远端肾小管尿钠排泄以及增加循环SDF-1α1-67！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e92d9988838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401937, encodeId=2dca140193e7b, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Circulation：主动脉瓣钙化治疗新靶点：DPP-4, objectType=article, longId=89723, objectId=090289e232c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=090289e232c, replyNumber=0, likeNumber=72, createdTime=2017-02-24, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=090289e232c, moduleTitle=Circulation：主动脉瓣钙化治疗新靶点：DPP-4, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=090289e232c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401936, encodeId=2c20140193634, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=DPP-4抑制剂治疗降低T2DM患者外周动脉疾病和下肢截肢风险, objectType=article, longId=87342, objectId=9ade8e342f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ade8e342f5, replyNumber=0, likeNumber=71, createdTime=2017-01-13, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ade8e342f5, moduleTitle=DPP-4抑制剂治疗降低T2DM患者外周动脉疾病和下肢截肢风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ade8e342f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DPP-4

2020-05-29

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？

2018-12-25

仁医06 (审核中...)

前往app查看评论内容

#DPP-4#

BMJ：DPP-4抑制剂以及GLP-1激动剂或导致糖尿病患者胆管癌风险增加

2018-12-13

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Int Immunopharmacol：在体外培养中DPP-4抑制剂对视网膜内皮细胞具有保护作用

2018-12-12

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类

2018-06-03

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！

2018-03-05

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：治疗2型糖尿病 SGLT-2is或比DPP-4is更胜一筹

2018-02-03

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星

2018-01-09

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Care：2型糖尿病GLP-1 RA和DPP-4治疗：真实世界有效性数据为何比RCT差？

2017-12-30

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Care：“调解官”二甲双胍能改善DPP-4抑制剂对心血管的影响？

2017-12-28

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：DPP-4抑制剂不对β细胞功能造成影响

2017-12-23

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Care：二甲双胍或可调节DPP-4抑制剂对心血管结局的影响。

2017-10-30

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：DPP-4抑制剂和SU治疗的HHF风险无组内差异

2017-10-27

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局

2017-10-14

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：2型糖尿病患者采用DPP-4i和达格列净治疗的效果比较！

2017-08-22

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：初始DPP-4是否增加老年糖尿病患者心血管事件风险？

2017-07-27

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Obes Metab：2型糖尿病患者采用DPP-4is和SGLT-2is治疗疗效和安全性比较！

2017-07-01

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

JAHA:DPP-4抑制剂阿拉格列丁能够抑制颅内动脉瘤的形成

2017-06-23

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Care：DPP-4抑制刺激2型糖尿病患者远端肾小管尿钠排泄以及增加循环SDF-1α1-67！

2017-05-28

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Circulation：主动脉瓣钙化治疗新靶点：DPP-4

2017-02-24

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

DPP-4抑制剂治疗降低T2DM患者外周动脉疾病和下肢截肢风险

2017-01-13

科室
- - 订阅+
  - 更多科室
工具
服务